Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
Yifan Meng, Wanrong Lu, Ensong Guo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Jinjin Zhang, Xiang Dong, Yiyuan Cao, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1730-1741
Open Access | Times Cited: 4078
D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
Litao Zhang, Xinsheng Yan, Qingkun Fan, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 6, pp. 1324-1329
Open Access | Times Cited: 1317
Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
Linlin Cheng, Haolong Li, Liubing Li, et al.
Journal of Clinical Laboratory Analysis (2020) Vol. 34, Iss. 10
Open Access | Times Cited: 365
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis
Farha Musharrat Noor, Md. Momin Islam
Journal of Community Health (2020) Vol. 45, Iss. 6, pp. 1270-1282
Open Access | Times Cited: 293
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis
Karla Romero Starke, David Reissig, Gabriela Petereit-Haack, et al.
BMJ Global Health (2021) Vol. 6, Iss. 12, pp. e006434-e006434
Open Access | Times Cited: 289
Systemic and organ-specific immune-related manifestations of COVID-19
Manuel Ramos‐Casals, Pilar Brito‐Zerón, Xavier Mariette
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 6, pp. 315-332
Open Access | Times Cited: 277
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
Mengzhen Dong, Jie Zhang, Xuefeng Ma, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110678-110678
Open Access | Times Cited: 237
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Julio García‐Suárez, Javier de la Cruz, Ángel Cedillo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 214
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 233-236
Open Access | Times Cited: 205
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis
Amirali Karimi, Parnian Shobeiri, Arutha Kulasinghe, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 74
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S. Pathania, Philip Prathipati, Abdul Bakrudeen Ali Ahmed, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 731-753
Open Access | Times Cited: 113
Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
Yin Yao, Hai Wang, Zheng Liu
Clinical & Experimental Allergy (2020) Vol. 50, Iss. 12, pp. 1313-1324
Open Access | Times Cited: 88
Haemophagocytic syndrome and COVID-19
Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 4, pp. 1233-1244
Open Access | Times Cited: 82
SOX9: An emerging driving factor from cancer progression to drug resistance
Munmun Panda, Surya Kant Tripathi, Bijesh K. Biswal
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188517-188517
Closed Access | Times Cited: 68
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
Predictors of mortality of COVID-19 in the general population and nursing homes
Pedro Pablo España, Amaia Bilbao, Susana García‐Gutiérrez, et al.
Internal and Emergency Medicine (2021) Vol. 16, Iss. 6, pp. 1487-1496
Open Access | Times Cited: 57
Ferritin level: A predictor of severity and mortality in hospitalized COVID‐19 patients
Moudhi Alroomi, Rajesh Rajan, Abdulaziz Alsayed Omar, et al.
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 4, pp. 1648-1655
Open Access | Times Cited: 56
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
Alvin Lee, Karin Purshouse
British Journal of Cancer (2021) Vol. 124, Iss. 11, pp. 1777-1784
Open Access | Times Cited: 51
Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study
Aliénor Xhaard, Constance Xhaard, Maud D’Aveni, et al.
British Journal of Haematology (2021) Vol. 192, Iss. 5
Open Access | Times Cited: 42
Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients
Giulia Di Felice, Giovanni Visci, Federica Teglia, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 34
SARS‐CoV‐2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?
Jungang Chen, Jiao Song, Lu Dai, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5103-5111
Open Access | Times Cited: 28
Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19
Magda Bucholc, Declan Bradley, Damien Bennett, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top